Drawing for LGO

USPTO serial 99548701

LGO

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MORRIS, ALINA S.
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with LGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $249*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

KEVIN FORTIN

KEVIN FORTIN FORTIN PATENT FIRMPO Box 400Rollinsville, CO 80474United States

Goods and services

ClassDescriptionStatusFirst use
005Nutraceuticals for use as a dietary supplement; Nutraceuticals for the treatment of anxiety, sleep disorders, mood, brain fog, muscular tone, pain, libido, immune function, inflammation, skin blemishes and wrinkles, liver function; Nutraceuticals for use as a dietary supplement for anxiety, sleep disorders, mood, brain fog, muscular tone, pain, libido, immune function, inflammation, skin blemishes and wrinkles, liver function; Synthetic peptides for the treatment of anxiety, sleep disorders, mood, brain fog, muscular tone, pain, libido, immune function, inflammation, skin blemishes and wrinkles, liver function; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of gummy candies that facilitate the delivery of pharmaceutical preparations; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Gummy vitamins; Nutritional supplements in the form of gummy candies and lozenges; Pharmaceutical preparations for the treatment of anxiety, sleep disorders, mood, brain fog, muscular tone, pain, libido, immune function, inflammation, skin blemishes and wrinkles, liver functionACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Jun 16, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 19, 2026DOCKASSIGNED TO EXAMINER—
Dec 15, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance